4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion

Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion

Study Description
Brief Summary:
Researchers are trying to determine if the impact of a concussion on the brain is affected by anesthesia and surgery.

Condition or disease Intervention/treatment Phase
Concussion, Brain Other: Neurocognitive Testing Not Applicable

Detailed Description:
All subjects will complete pre and post procedure assessments prior to undergoing a planned surgery/anesthetic standard of care.
Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion
Actual Study Start Date : February 21, 2019
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2022
Arms and Interventions
Arm Intervention/treatment
Experimental: Concussion Group
Subjects diagnosed with concussion defined as a clinician-diagnosed disease by the International Classification of Diseases (ICD)-10 due to a head injury with a Glasgow Coma Score ≥13 undergoing a planned surgery/anesthetic standard of care will undergo neurocognitive testing pre and post surgery/anesthetic.
Other: Neurocognitive Testing
A comprehensive assessment of neuropsychometric measures to evaluate cognitive functioning.

Experimental: Matched Subjects Group
Matched subjects without concussion undergoing a planned surgery/anesthetic standard of care, matching for procedural type, sex, age ± 2 years, and adherence to the exclusion criteria will undergo neurocognitive testing pre and post surgery/anesthetic.
Other: Neurocognitive Testing
A comprehensive assessment of neuropsychometric measures to evaluate cognitive functioning.

Outcome Measures
Primary Outcome Measures :
  1. Wide Range Achievement Test Fourth Edition, WRAT-4 [ Time Frame: Pre-anesthetic to one week Post-anesthetic ]
    Change in WRAT-4


Secondary Outcome Measures :
  1. Numeric Pain Scale 0-10 [ Time Frame: Post-operatively to hospital discharge, up to 10 days. ]
    Difference in numeric pain scale between the concussion and non-concussion group. Patients verbally select a value that is in line with the intensity of pain they have experienced in the last 24 hours. Pain Scale is recorded "0" = no pain, "10" = the most pain imaginable.

  2. Oral morphine equivalent of consumed opioids [ Time Frame: Post-operatively to hospital discharge, up to 10 days. ]
    Difference of post-operative opioid use between the concussion and non-concussion group

  3. Length of hospital stay [ Time Frame: Post-operatively to hospital discharge, up to 30 days. ]
    Difference between the concussion and non-concussion group

  4. Cognitive Deficits identified by NeuroPsychometric Cognitive Testing [ Time Frame: Pre-anesthetic to one week Post-anesthetic ]
    Difference between the concussion and non-concussion group.

  5. Sport Concussion Assessment Tool - 5th edition, SCAT-5 [ Time Frame: Pre-anesthetic to one week Post-anesthetic ]
    The SCAT5 is a standardized tool for evaluating concussions designed for use by physicians and licensed medical professionals. Difference in SCAT5 scores between the concussion and non-concussion group. SCAT5 scores the number of symptoms (0-22) present and the severity of symptoms (0-132).


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male or Female >16 years of age with a recent concussion (<10 weeks) from planned procedure under anesthesia.

Exclusion Criteria:

  • Neurologic history including history of severe cognitive disease, disorder, or delay, attention disorder, moderate to severe TBI history, neurovascular order or trauma.
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Amy L Amsbaugh 507-538-7538 amsbaugh.amy@mayo.edu
Contact: Brenda Anderson 507-255-7157 anderson.brenda@mayo.edu

Locations
Layout table for location information
United States, Minnesota
Mayo Clinic in Rochester Recruiting
Rochester, Minnesota, United States, 55905
Contact: Amy L Amsbaugh         
Principal Investigator: Arnoley S Abcejo, MD         
Sponsors and Collaborators
Mayo Clinic
Investigators
Layout table for investigator information
Principal Investigator: Arnoley S Abcejo, MD Mayo Clinic
Tracking Information
First Submitted Date  ICMJE April 9, 2019
First Posted Date  ICMJE May 16, 2019
Last Update Posted Date August 18, 2020
Actual Study Start Date  ICMJE February 21, 2019
Estimated Primary Completion Date December 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 14, 2019)
Wide Range Achievement Test Fourth Edition, WRAT-4 [ Time Frame: Pre-anesthetic to one week Post-anesthetic ]
Change in WRAT-4
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: August 13, 2019)
  • Numeric Pain Scale 0-10 [ Time Frame: Post-operatively to hospital discharge, up to 10 days. ]
    Difference in numeric pain scale between the concussion and non-concussion group. Patients verbally select a value that is in line with the intensity of pain they have experienced in the last 24 hours. Pain Scale is recorded "0" = no pain, "10" = the most pain imaginable.
  • Oral morphine equivalent of consumed opioids [ Time Frame: Post-operatively to hospital discharge, up to 10 days. ]
    Difference of post-operative opioid use between the concussion and non-concussion group
  • Length of hospital stay [ Time Frame: Post-operatively to hospital discharge, up to 30 days. ]
    Difference between the concussion and non-concussion group
  • Cognitive Deficits identified by NeuroPsychometric Cognitive Testing [ Time Frame: Pre-anesthetic to one week Post-anesthetic ]
    Difference between the concussion and non-concussion group.
  • Sport Concussion Assessment Tool - 5th edition, SCAT-5 [ Time Frame: Pre-anesthetic to one week Post-anesthetic ]
    The SCAT5 is a standardized tool for evaluating concussions designed for use by physicians and licensed medical professionals. Difference in SCAT5 scores between the concussion and non-concussion group. SCAT5 scores the number of symptoms (0-22) present and the severity of symptoms (0-132).
Original Secondary Outcome Measures  ICMJE
 (submitted: May 14, 2019)
  • Pain Scores 0-10 scale [ Time Frame: Post-operatively to hospital discharge, up to 10 days. ]
    Difference between the concussion and non-concussion group
  • Opioid Use [ Time Frame: Post-operatively to hospital discharge, up to 10 days. ]
    Difference between the concussion and non-concussion group
  • Length of hospital stay [ Time Frame: Post-operatively to hospital discharge, up to 30 days. ]
    Difference between the concussion and non-concussion group
  • Cognitive Deficits identified by NeuroPsychometric Cognitive Testing [ Time Frame: Pre-anesthetic to one week Post-anesthetic ]
    Difference between the concussion and non-concussion group
  • Sport Concussion Assessment Tool, SCAT [ Time Frame: Pre-anesthetic to one week Post-anesthetic ]
    Difference between the concussion and non-concussion group
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion
Official Title  ICMJE Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion
Brief Summary Researchers are trying to determine if the impact of a concussion on the brain is affected by anesthesia and surgery.
Detailed Description All subjects will complete pre and post procedure assessments prior to undergoing a planned surgery/anesthetic standard of care.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Condition  ICMJE Concussion, Brain
Intervention  ICMJE Other: Neurocognitive Testing
A comprehensive assessment of neuropsychometric measures to evaluate cognitive functioning.
Study Arms  ICMJE
  • Experimental: Concussion Group
    Subjects diagnosed with concussion defined as a clinician-diagnosed disease by the International Classification of Diseases (ICD)-10 due to a head injury with a Glasgow Coma Score ≥13 undergoing a planned surgery/anesthetic standard of care will undergo neurocognitive testing pre and post surgery/anesthetic.
    Intervention: Other: Neurocognitive Testing
  • Experimental: Matched Subjects Group
    Matched subjects without concussion undergoing a planned surgery/anesthetic standard of care, matching for procedural type, sex, age ± 2 years, and adherence to the exclusion criteria will undergo neurocognitive testing pre and post surgery/anesthetic.
    Intervention: Other: Neurocognitive Testing
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: May 14, 2019)
60
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE December 2022
Estimated Primary Completion Date December 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Male or Female >16 years of age with a recent concussion (<10 weeks) from planned procedure under anesthesia.

Exclusion Criteria:

  • Neurologic history including history of severe cognitive disease, disorder, or delay, attention disorder, moderate to severe TBI history, neurovascular order or trauma.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 16 Years and older   (Child, Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE
Contact: Amy L Amsbaugh 507-538-7538 amsbaugh.amy@mayo.edu
Contact: Brenda Anderson 507-255-7157 anderson.brenda@mayo.edu
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03952208
Other Study ID Numbers  ICMJE 18-006578
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Arnoley (Arney) S. Abcejo, Mayo Clinic
Study Sponsor  ICMJE Mayo Clinic
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Arnoley S Abcejo, MD Mayo Clinic
PRS Account Mayo Clinic
Verification Date August 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP